Periodic Versus Continuous IV Iron Supplementation in HD Patients

Papageorgiou General Hospital27 enrolled

Overview

The purpose of this study was to compare the efficacy of two regimens of intravenous iron sucrose \[continuous (in every hemodialysis session) versus intermittent (every 1-4 weeks)\] on the response of rHuEPO in the maintenance phase of its administration in hemodialysis patients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Anemia of Chronic Kidney Disease

Interventions

Iron Sucrose SupplementDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Constant rHu-EPO and iron dose for at least 2 months before starting the study * Hemoglobin ≥ 8,5g/dl and \<12,5 g/dl * Ferritin \< 1000 mg/dl * TSAT \< 50% * CRP \< 5 mg/dl Exclusion Criteria: * Malignant tumor disease * Oral iron supplementation * Active bleeding issues * Surgical intervention within the last 8 weeks before study inclusion

Locations (1)

Papageorgiou General Hospital

Thessaloniki, Greece

Outcomes

Primary Outcomes

Change of serum hemoglobin level (g/dl)

Time frame: Month 0, 1, 2, 3, 4

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.